Author: Rudski, Lawrence; Januzzi, James L.; Rigolin, Vera H.; Bohula, Erin A.; Blankstein, Ron; Patel, Amit R.; Bucciarelli-Ducci, Chiara; Vorovich, Esther; Mukherjee, Monica; Rao, Sunil V.; Beanlands, Rob; Villines, Todd C.; Di Carli, Marcelo F.
Title: Multimodality Imaging in Evaluation of Cardiovascular complications in Patients with COVID-19 Cord-id: b0yufidn Document date: 2020_7_22
ID: b0yufidn
Snippet: Abstract Standard evaluation and management of the patient with suspected or proven cardiovascular complications of COVID-19, the disease caused by severe acute respiratory syndrome–related coronavirus-2 (SARS-CoV-2), is challenging. Routine history, physical examination, laboratory testing, electrocardiography and plain x-ray imaging may often suffice for such patients but given overlap between COVID-19 and typical cardiovascular diagnoses such as heart failure and acute myocardial infarction
Document: Abstract Standard evaluation and management of the patient with suspected or proven cardiovascular complications of COVID-19, the disease caused by severe acute respiratory syndrome–related coronavirus-2 (SARS-CoV-2), is challenging. Routine history, physical examination, laboratory testing, electrocardiography and plain x-ray imaging may often suffice for such patients but given overlap between COVID-19 and typical cardiovascular diagnoses such as heart failure and acute myocardial infarction, need frequently arises for advanced imaging techniques to assist in differential diagnosis and management. This document provides guidance in several common scenarios among patients with confirmed or suspected COVID-19 infection and possible cardiovascular involvement, including chest discomfort with electrocardiographic changes, acute hemodynamic instability, newly-recognized left ventricular dysfunction, as well as imaging during the sub-acute/chronic phase of COVID-19. For each, we consider the role of biomarker testing to guide imaging decision-making, provide differential diagnostic considerations, and offer general suggestions regarding application of various advanced imaging techniques. Condensed Abstract Standard evaluation and management of the patient with suspected or proven cardiovascular complications due to COVID-19 infection often requires advanced imaging techniques to assist in differential diagnosis and management. This document provides guidance in several common scenarios among patients with COVID-19 infection and for each provides advice regarding the role of biomarker testing to guide imaging decision-making, provides differential diagnostic considerations, and offers general suggestions regarding application of various advanced imaging techniques.
Search related documents:
Co phrase search for related documents- acute phase and liver function: 1, 2, 3, 4, 5, 6, 7
- acute phase and local expertise: 1
- acute phase and long hospital stay: 1
- acute phase and long term consequence: 1, 2, 3
- acute phase and low cardiac output: 1
- acute phase and low voltage: 1, 2
- acute phase and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- acute phase and lv dysfunction: 1, 2, 3, 4
- acute phase and lv function: 1, 2, 3, 4, 5, 6, 7
- acute phase and lv systolic dysfunction: 1, 2, 3, 4
- acute phase and lv systolic function: 1, 2, 3, 4, 5, 6
- acute phase and lymphocytic infiltration: 1, 2
- liver function and lung disease: 1, 2, 3, 4, 5, 6, 7
- liver function and lv dysfunction: 1
- liver function and lv systolic dysfunction: 1
- local expertise and lung disease: 1
- lv dilatation and lv function: 1, 2
- lv dilatation and lv systolic dysfunction: 1, 2, 3
- lv dilatation and lv systolic function: 1, 2
Co phrase search for related documents, hyperlinks ordered by date